19th Regulatory and Scientific Affairs Conference

Remedica attended the “19th Regulatory and Scientific Affairs Conference” which took place between the 30th and 31st of January 2020 in Amsterdam, Holland. Mr Nikolas Ladas, Chief Portfolio Officer, and Dr Sylvana Papaioannou, Registration Manager of the company represented Remedica at this conference.

The aim of the conference was to further the participants’ knowledge of recent regulatory and scientific topics affecting their daily work. The programme of the conference was very interesting with topics such as the future strategy for pharmaceuticals until 2025, the availability of medicines and the modernization of the variations system and the variations regulation in the EU.

The conference was a great success having achieved its aims and having engaged all stakeholders in stimulating dialogue.